| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ARR3
|
arrestin 3, retinal (X-arrestin)
|
|
ASRGL1
|
asparaginase like 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
CARTPT
|
CART prepropeptide
|
|
CASR
|
calcium-sensing receptor
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD19
|
CD19 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD47
|
CD47 molecule
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CHEK1
|
checkpoint kinase 1
|
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
|
|
CPA3
|
carboxypeptidase A3 (mast cell)
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CREBBP
|
CREB binding protein
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
DCK
|
deoxycytidine kinase
|
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
EBP
|
emopamil binding protein (sterol isomerase)
|
|
ELL
|
elongation factor RNA polymerase II
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FAS
|
Fas cell surface death receptor
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
GATA2
|
GATA binding protein 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HOXB9
|
homeobox B9
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IL2
|
interleukin 2
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KLRC4-KLRK1
|
KLRC4-KLRK1 readthrough
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MME
|
membrane metallo-endopeptidase
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MPO
|
myeloperoxidase
|
|
MT1E
|
metallothionein 1E
|
|
MTF2
|
metal response element binding transcription factor 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUP98
|
nucleoporin 98kDa
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PHF6
|
PHD finger protein 6
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCH
|
protein kinase C, eta
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TBX22
|
T-box 22
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TP53
|
tumor protein p53
|
|
TRIM13
|
tripartite motif containing 13
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
